Home » Topics » Regulatory » EMA

EMA
RSS

Lilly withdraws E.U. marketing authorization application for Arxxant

April 10, 2007

No Comments

EMEA recommends restrictions on use of Ketek

April 4, 2007

No Comments

Orencia recommended for approval in E.U. for rheumatoid arthritis

April 2, 2007

No Comments

European CHMP hands down positive opinions for Xyrem and Prevenar

Jan. 30, 2007

No Comments

Sprycel approved in E.U.

Dec. 1, 2006

No Comments

Microdosing/phase 0 trials: Paradigm shift aims to speed new drug development, improve efficiency

Nov. 7, 2006

No Comments

Aldara recommended for approval for actinic keratosis in Europe

Oct. 23, 2006

No Comments

Positive opinion handed down in Europe for new Glivec indication

Oct. 23, 2006

No Comments

Europe's CHMP recommends Hycamtin for new indication

Oct. 23, 2006

No Comments

Tandemact recommended for approval in E.U.

Oct. 23, 2006

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

EMA
RSS

Lilly withdraws E.U. marketing authorization application for Arxxant

EMEA recommends restrictions on use of Ketek

Orencia recommended for approval in E.U. for rheumatoid arthritis

European CHMP hands down positive opinions for Xyrem and Prevenar

Sprycel approved in E.U.

Microdosing/phase 0 trials: Paradigm shift aims to speed new drug development, improve efficiency

Aldara recommended for approval for actinic keratosis in Europe

Positive opinion handed down in Europe for new Glivec indication

Europe's CHMP recommends Hycamtin for new indication

Tandemact recommended for approval in E.U.

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

‘Evo’ AI can design complete genomes

EMA RSS

EMA
RSS